1. Home
  2. Labeler Index
  3. A-s Medication Solutions
  4. 50090-5574
  5. Product Images: Alogliptin

Product Images Alogliptin

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 6 images provide visual information about the product associated with Alogliptin NDC 50090-5574 by A-s Medication Solutions, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

Chemical Structure - alogliptin 01

Chemical Structure - alogliptin 01

Figure 1 - alogliptin 02

Figure 1 - alogliptin 02

This text appears to be a list of different dosages and administration recommendations for the medication Alogliptin, as well as interactions with other drugs. Alogliptin is a substrate for several enzymes, including CYP1A2, CYP2C8, CYP2CS, CYP2D6, CYP3A4, and Pgp. The text also includes information on the renal excretion of Alogliptin and recommendations for coadministration with other drugs such as Metformin, Cimetidine, Pioglitazone, Warfarin, Glyburide, Tolbutamide, Dextromethorphan, Atorvastatin, Ethinyl Estradiol, Norethindrone, Midazolam, Digoxin, and Fexofenadine. There is no information provided on the purpose or use of Alogliptin itself.*

Figure 2 - alogliptin 03

Figure 2 - alogliptin 03

This appears to be a list of medications and their dosages in relation to their effect on various enzymes in the body. The list includes information on drugs that either inhibit or are substrates of certain enzymes with recommended dosage adjustments or no adjustments needed. One of the medications, Alogliptin, is mentioned multiple times with various doses and single-dose options, but a clear recommendation for dosage adjustment is not given.*

Figure 3 - alogliptin 04

Figure 3 - alogliptin 04

This is a table or chart displaying different mean A1C values and changes in A1C for a study comparing the effectiveness of a placebo, Alogliptin, Pioglitazone, and a combination of Alogliptin and Pioglitazone. The study was conducted on an intent-to-treat population using the last observation on the study, and the results are compared using p-values.*

Figure 4 - alogliptin 05

Figure 4 - alogliptin 05

The text appears to be a section of a medical study report, comparing the effectiveness of NESINA and Placebo medication for a certain condition. The report mentions the comparison between NESINA and Placebo regarding HR (heart rate) and provides some statistical figures in table form, indicating the number of people at risk and the duration of the treatment.*

Label Image - lbl500905574

Label Image - lbl500905574

This description provides information about a product T BHA-O labeled as "hCocLeTin 25 MG." It appears to contain 30 tablets and requires storage at a certain temperature ("SToRE AT 7 REES £"). However, the initial text "1mc, zotpe" is not clear and might not be relevant to the product description.*

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.